MARLBOROUGH, Mass., February 20, 2025--(BUSINESS WIRE)--Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines ...

Notably, the system was launched in 2017 and has been designed for use with Hologic’s Affirm Prone biopsy guidance system. Per the company, the Brevera system is the world’s first and only ...

Last week, Hologic HOLX earned two key regulatory approvals. The company’s Affirm Contrast Biopsy software has earned the CE Mark, having previously been cleared by the FDA in October 2020.

The CE-Marked Affirm™ Prone Biopsy System Provides Enhanced 2D/3D™ Biopsy Imaging and Faster, Easier Access to the Breast [i] MARLBOROUGH, Massachusetts, March 2, 2016 /PRNewswire/ -- Hologic ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

attendees can experience Hologic’s Dimensions ® mammography portfolio, Envision Mammography Platform, Genius AI Detection 2.0 and Genius AI Detection PRO software, Affirm ® Contrast Biopsy ...

Among the full suite of breast biopsy and surgery solutions will be Hologic’s Affirm® Contrast Biopsy software, which will be on display for the first time since becoming ...

Pete Valenti, Hologic's Division President, Breast and Skeletal Health Solutions said, 'The launch of our Affirm prone biopsy system is the most significant advancement in prone biopsy technology ...

MARLBOROUGH, Mass., February 20, 2025--(BUSINESS WIRE)--Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines ...

Designed from the ground up to integrate with the Selenia Dimensions and 3Dimensions systems, Hologic's Affirm Contrast Biopsy Software enables clinicians to target and acquire tissue samples in ...